Sort   by:  
 Page size 
UnknownCD19-directed CAR T-cell therapy for treatment of primary CNS lymphoma.
Not available
S-EPMC8945630 | biostudies-literature
UnknownT Cell-intrinsic Immunomodulatory Effects of TAK-981 (Subasumstat), a SUMO-activating Enzyme Inhibitor, in Chronic Lymphocytic Leukemia.
Not available
S-EPMC10525033 | biostudies-literature
UnknownObjective responses in relapsed T-cell lymphomas with single-agent brentuximab vedotin.
Not available
S-EPMC4425442 | biostudies-literature
UnknownPharmacologic targeting of Nedd8-activating enzyme reinvigorates T-cell responses in lymphoid neoplasia.
Not available
S-EPMC10244170 | biostudies-literature
UnknownMolecular rDNA phylogeny of Telotylenchidae Siddiqi, 1960 and evaluation of tail termini.
Not available
S-EPMC3380519 | biostudies-literature
UnknownThe Cerebroventricular Environment Modifies CAR T Cells for Potent Activity against Both Central Nervous System and Systemic Lymphoma.
Not available
S-EPMC8008993 | biostudies-literature
UnknownMolecular, structural, and functional characterization of delta subunit of T-complex protein-1 from <i>Leishmania donovani</i>.
Not available
S-EPMC11475657 | biostudies-literature
UnknownPhase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma.
Not available
S-EPMC5363293 | biostudies-literature
UnknownPhase 1 studies of central memory-derived CD19 CAR T-cell therapy following autologous HSCT in patients with B-cell NHL.
Not available
S-EPMC4911862 | biostudies-literature
UnknownConduction in the Heart Wall: Helicoidal Fibers Minimize Diffusion Bias.
Not available
S-EPMC5940931 | biostudies-literature
Sort   by:  
 Page size